Draft:Paul Dalby

Review waiting, please be patient. This may take 3 months or more, since drafts are reviewed in no specific order. There are 2,499 pending submissions waiting for review. If the submission is accepted, then this page will be moved into the article space. If the submission is declined, then the reason will be posted here. In the meantime, you can continue to improve this submission by editing normally. Where to get help If you need help editing or submitting your draft, please ask us a question at the AfC Help Desk or get live help from experienced editors. These venues are only for help with editing and the submission process, not to get reviews. If you need feedback on your draft, or if the review is taking a lot of time, you can try asking for help on the talk page of a relevant WikiProject. Some WikiProjects are more active than others so a speedy reply is not guaranteed. How to improve a draft Wikipedia:Contributing to Wikipedia – a basic overview on how to edit Wikipedia. Help:Wikitext – how to use the markup Help:Referencing for beginners – how to include references Wikipedia:Article development – how to develop your article Wikipedia:Writing better articles – how to improve your article third-party sources You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Add tags to your draft Editor resources Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL Easy tools: Citation bot (help) | Advanced: Fix bare URLs Reviewer tools Instructions · What links here · Paul Dalby (talk: + · bio) · (log) · Copyvios report · reFill · Citation Bot · (Search: Google, Bing, Wikipedia) · Submitted 22 days ago by Ucbepad (talk: D · +) · Last edited 21 days ago by Citation bot

Paul Dalby (born 8 August 1973) is a British chemist and biochemist. He is a professor of Biochemical Engineering and Biotechnology.^[1] and co-director of the Future Targeted Healthcare Manufacturing Hub^[2] at University College London, where he is also Deputy Head of the Department of Biochemical Engineering.^[3]

Early life and education

Dalby was born on 8 August 1973 in Northampton, UK. He attended Sponne School (1984–1991), and read Natural Sciences at Gonville and Caius College, University of Cambridge from 1991. Dalby was awarded a Master of Artsdegree in Natural Sciences from the University of Cambridge in 1994, and carried out undergraduate research with Prof. D. H. Williams (chemistry). He obtained his PhD in protein folding and engineering from the University of Cambridge in 1998 under the supervision of Sir Alan Fersht at the MRC Centre for Protein Engineering.

Career

Dalby undertook post-doctoral research with Prof William DeGrado at the University of Pennsylvania (1998–2000), before accepting a Lectureship in Biochemical Engineering at University College London in 2000.

In 2013, Dalby was appointed Professor of Biochemical Engineering and Biotechnology at University College London, where he continues to work.

Dalby was Director of the EPSRC Centre for Doctoral Training in Innovative Manufacturing in Emergent Macromolecular Therapies (2012-2022), Co-Director of the EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies (2011-2016), and Co-Director of the EPSRC Future Targeted Healthcare Manufacturing Hub (2016-2024)^[2]. From 2008 to 2023 Dalby was Chair of the Royal Society of Chemistry Biotechnology Group.

Research

Dalby applies chemical, biophysical and process engineering methods and principles to understand the properties of proteins, and then engineer or formulate them for use as therapeutics, vaccines or biocatalysts.

He is interested in the protein aggregation mechanisms^[4], and also how excipients stabilise therapeutic protein products^[5] for applications in biotechnology.

Dalby has pioneered several strategies for combining rational, evolutionary and computational design tools, to engineer enzymes and therapeutic proteins with altered functions or improved stability.^[6][7][8]

The current focuses of his group^[9] are in the re-engineering and formulation of proteins, including viral vectors used in gene therapy.

Awards and honours

• 2023 – Royal Society of Chemistry Long Service Award
• 2010 – IChemE Bioprocessing Award^[10]
• 2010 – Royal Society of Chemistry Rita and John Cornforth Award.^[11]
• 2008 – Evonik European Science-to-Business Award ^[12]

References